Načítá se...
5-ALA and FDA Approval for Glioma Surgery
The U.S. Food and Drug Administration (FDA) approved 5-ALA (Gleolan®; photonamic GmbH & Co. KG) for use as an intraoperative optical imaging agent in patients with suspected high-grade gliomas (HGGs) in 2017. This was the first ever optical imaging agent approved as an adjunct for the visualizat...
Uloženo v:
| Vydáno v: | J Neurooncol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6445645/ https://ncbi.nlm.nih.gov/pubmed/30644008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-019-03098-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|